These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 23018127)
21. Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism. Huang M; Panos JJ; Kwon S; Oyamada Y; Rajagopal L; Meltzer HY J Neurochem; 2014 Mar; 128(6):938-49. PubMed ID: 24164459 [TBL] [Abstract][Full Text] [Related]
22. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism. du Jardin KG; Jensen JB; Sanchez C; Pehrson AL Eur Neuropsychopharmacol; 2014 Jan; 24(1):160-71. PubMed ID: 23916504 [TBL] [Abstract][Full Text] [Related]
23. The ameliorative effects and underlying mechanisms of dopamine D1-like receptor agonist SKF38393 on Aβ Zang X; Cheng ZY; Sun Y; Hua N; Zhu LH; He L Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():250-261. PubMed ID: 28939187 [TBL] [Abstract][Full Text] [Related]
24. Modulation of the effects of the cannabinoid agonist, ACPA, on spatial and non-spatial novelty detection in mice by dopamine D1 receptor drugs infused into the basolateral amygdala. Mohammadi M; Nasehi M; Zarrindast MR Behav Brain Res; 2015 Mar; 280():36-44. PubMed ID: 25476564 [TBL] [Abstract][Full Text] [Related]
25. SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit. Terranova JP; Chabot C; Barnouin MC; Perrault G; Depoortere R; Griebel G; Scatton B Psychopharmacology (Berl); 2005 Aug; 181(1):134-44. PubMed ID: 15830220 [TBL] [Abstract][Full Text] [Related]
26. Neurosteroid pregnenolone sulfate, alone, and as augmentation of lurasidone or tandospirone, rescues phencyclidine-induced deficits in cognitive function and social interaction. Rajagopal L; Soni D; Meltzer HY Behav Brain Res; 2018 Sep; 350():31-43. PubMed ID: 29763637 [TBL] [Abstract][Full Text] [Related]
27. Activation of dopamine D1 receptors in the medial septum improves scopolamine-induced amnesia in the dorsal hippocampus. Zarrindast MR; Ardjmand A; Ahmadi S; Rezayof A Behav Brain Res; 2012 Apr; 229(1):68-73. PubMed ID: 22226623 [TBL] [Abstract][Full Text] [Related]
28. Blonanserin ameliorates phencyclidine-induced visual-recognition memory deficits: the complex mechanism of blonanserin action involving D₃-5-HT₂A and D₁-NMDA receptors in the mPFC. Hida H; Mouri A; Mori K; Matsumoto Y; Seki T; Taniguchi M; Yamada K; Iwamoto K; Ozaki N; Nabeshima T; Noda Y Neuropsychopharmacology; 2015 Feb; 40(3):601-13. PubMed ID: 25120077 [TBL] [Abstract][Full Text] [Related]
29. Blockade of the dorsal hippocampal dopamine D1 receptors inhibits the scopolamine-induced state-dependent learning in rats. Piri M; Rostampour M; Nasehi M; Zarrindast MR Neuroscience; 2013 Nov; 252():460-7. PubMed ID: 23933216 [TBL] [Abstract][Full Text] [Related]
30. Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia. Meltzer HY; Rajagopal L; Huang M; Oyamada Y; Kwon S; Horiguchi M Int J Neuropsychopharmacol; 2013 Nov; 16(10):2181-94. PubMed ID: 24099265 [TBL] [Abstract][Full Text] [Related]
37. Effect of transient blockade of N-methyl-D-aspartate receptors at neonatal stage on stress-induced lactate metabolism in the medial prefrontal cortex of adult rats: role of 5-HT1A receptor agonism. Uehara T; Itoh H; Matsuoka T; Rujescu D; Genius J; Seo T; Sumiyoshi T Synapse; 2012 May; 66(5):408-17. PubMed ID: 22213269 [TBL] [Abstract][Full Text] [Related]
38. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822. Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023 [TBL] [Abstract][Full Text] [Related]
39. Direct inhibition of the N-methyl-D-aspartate receptor channel by dopamine and (+)-SKF38393. Castro NG; de Mello MC; de Mello FG; Aracava Y Br J Pharmacol; 1999 Apr; 126(8):1847-55. PubMed ID: 10372829 [TBL] [Abstract][Full Text] [Related]
40. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors. Gogos A; Kwek P; Chavez C; van den Buuse M J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]